Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

The first time around

Article Abstract:

UK tax exempt special savings accounts (Tessas) have shown a wide range of performance in the five years to 1996. Fixed-rate Tessas have tended to perform well as interest rates have dropped. Fixed-rate Tessas account for the best five Tessas in terms of performance. Smaller building societies have also tended to perform well, while larger companies argue that they provide greater security which is why their products do not perform as well.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
United Kingdom, Prices and rates, Savings and loan associations, Savings accounts

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The $5-million man

Article Abstract:

The aims of Marc de Jordy, one of the team behind Canada's bid to launch a manned reusable rocket into sub-orbit, are discussed. The group will launch a 20ft rocket from a hot-air balloon at 40,000 ft. in an international competition.

Author: Neblett, Andrea
Publisher: The Canadian Institute of Chartered Accountants
Publication Name: CA Magazine
Subject: Business
ISSN: 0317-6878
Year: 2000
Canada, Finance, Interview, Manned space flight, Competitions, Rocket research, Rocketry

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Similar abstracts:
  • Abstracts: The pursuit of design mindfulness. Design under the gun. Canada's comprehensive design study
  • Abstracts: Costar Stingray. Streamlined screens. UK: HIGHER COSTS FOR PET BOTTLES A CONCERN
  • Abstracts: Taming the risks in emerging markets. Marten Transport, Ltd. (MRTN)
  • Abstracts: Watch for speed bumps ahead. Worlds in collision. Against all odds
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.